CETIRIZINE HYDROCHLORIDE Recall D-0348-2025
Description: Cetirizine Hydrochloride Tablets, USP, 10mg, 365-count packs, Rx Only, Manufactured for: Glenmark Therapeutics Inc., Distributed by: Amazon. NDC# 72657-129-35
CETIRIZINE HYDROCHLORIDE Recall D-0348-2025 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0348-2025 |
Event ID | 96474 |
Brand | CETIRIZINE HCL |
Generic Name | CETIRIZINE |
Manufacturer | CETIRIZINE |
Original Package? | 1 |
Active Substance | CETIRIZINE HYDROCHLORIDE |
Drug Route | ORAL |
Distribution | U.S. Nationwide |
Quantity | N/A |
Recall Reason | CGMP Deviations |
Drug Classification | Class II |
Drug Code Info | 20250416 |
Product NDC | 72657-128 72657-129 72657-130 |
Drug UPC | 0372657129350 0372657128353 |
Recall Initiation Date | 20250313 |
Report Date | 20250416 |
Classification Date | 20250408 |
Address | 750 Corporate DrN/A Mahwah, NJ 07430-2009 United States |
Recalling Firm | Glenmark Pharmaceuticals Inc., USA |
Initial Notification | Letter |
Unique Ingredient Identifier | 64O047KTOA |
Drug Application Number | ANDA078427 |
Structured Product Labeling (SPL ID) | fd1924df-96c1-4429-944d-bd09a7dd2a6b |
Structured Product Labeling (SPL Set ID) | 04b08c52-5390-4cdb-a9e7-fca81fffdc73 |
Similar To |